Fertility-Sparing Surgery for Early-Stage Uterine Cervical Cancer
Cervical cancer is the second most common gynecological cancer, and approximately 45% are diagnosed in women younger than 40 years. In Western societies, in which women tend to delay childbearing and cervical cancer incidence peaks within the third decade of life, fertility-sparing treatment options have become a major issue.
In recent years, radical trachelectomy with pelvic lymphadenectomy has become an option for young patients with early-stage minimally invasive cervical cancers (stages IB1 or less) who wish to conserve their uterus, in order to preserve their fertility. Multiple studies have demonstrated the safety and feasibility of radical trachelectomy, as well as acceptable obstetrical outcomes. The aim of this chapter is to answer the main issues on this topic, such as surgical techniques, patient selection, and oncological and obstetric outcomes, according to the evidence published to date.
KeywordsFertility-sparing surgery Uterine cancer surgery and fertility sparing Early-stage uterine cervical cancer Cervical cancer Cervical cancer incidence
- 4.Edwards BK, Noone A-M, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual report to the nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290–314.CrossRefGoogle Scholar
- 7.Dargent D, Burn JL, Roy M, La trachélectomie élargie (T.E.). Une alternative á l’hystérectomie radicale dans le traitment des cancers infiltrants développés sur la face externe du col úterin. J Obstet Gynecol. 1994;2:292–5.Google Scholar
- 21.Halaska MJ, Robova H, Pluta M, Rob L. The role of trachelectomy in cervical cancer. E Cancer Med Sci. 2015;9:506.Google Scholar
- 29.Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer (CC): result from the Italian multicenter randomized study. J Clin Oncol. 2002;20(1):179–88.CrossRefGoogle Scholar